Huadong Medicine Co

Company snapshot

Established in 1993, Huadong Medicine Co.,Ltd specializes in the production and sales of antibiotic, Chinese patent medicine, synthetic drug, genetic engineering drugs, as well as wholesale business of Chinese and western medicine, Chinese herbal medicines, medical apparatus and instruments. The company is a large comprehensive listed pharmaceutical company integrated with pharmaceutical R&D, phar

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Huadong Medicine Co. Not investment advice.

• What is Huadong Medicine Co?

  Hangzhou Zhongmei Huadong is a pharma organization headquartered in CN. Primary therapeutic focus areas include Kidney Diseases. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPT

• Is Huadong Medicine Co publicly traded?

  Huadong Medicine Co appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Huadong Medicine Co develop or market?

  We link 1 drug profile(s) where Huadong Medicine Co is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/hangzhou-zhongmei-huadong-pharmaceutical-co#company-drugs.

• What are the latest developments for Huadong Medicine Co?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Huadong Medicine Co focus on?

  Huadong Medicine Co focuses on Kidney Diseases based on our analysis of their pipeline programs and drug development activities.